Tag: PD-L1

Downregulation of the transcription factor RFX2 promotes immune escape and tumor progression in lung adenocarcinoma by suppressing RASSF1 and reducing ...

A systematic review and meta-analysis of lung cancer immunotherapy trials finds lower peripheral but higher central neurological immune-related adverse event ...

A review in Cancer Cell International details how hypoxia-inducible factors drive immune evasion in head and neck squamous cell carcinoma, ...

A new study in Frontiers in Oncology reveals that PD-L1 deletion or blockade in macrophages consistently reduces surface levels of ...

A cohort study of hospitalized patients found that individuals living with HIV experienced significantly longer SARS-CoV-2 shedding and lower early ...

A multicenter study reveals that early gastric carcinoma with lymphoid stroma carries a significantly lower rate of lymph node metastasis ...

Engineered exosome-liposome hybrid nanoparticles targeting CSF1R and PD-L1 stimulate macrophage phagocytosis across several brain cancer cell models in vitro, though ...

A new review finds AI-derived biomarkers show promising, though variable, performance in predicting cancer immunotherapy response across tumor types.

A new study reveals that circular RNA CD47 promotes non-small cell lung cancer progression and immune evasion by stabilizing PD-L1 ...

Researchers developed a multiplexed immunoassay that measures immune checkpoint proteins on the surface of plasma extracellular vesicles and found generally ...